Determination of minalrestat (an aldose reductase inhibitor) in rat, dog and human plasma by high-performance liquid chromatography

Journal of Chromatography B: Biomedical Applications

Volumn 709, Issue 1, 1998, Pages 127-135

  Tse, S Y H ^a   Whetsel, R ^a  

^a PFIZER INC   (United States)

Author keywords

Aldose reductase inhibitor; Minalrestat

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; MINALRESTAT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DOG; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NONHUMAN; NORMAL HUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SOLID PHASE EXTRACTION;

ALDEHYDE REDUCTASE; ANIMALS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; DRUG STABILITY; ENZYME INHIBITORS; HUMANS; RATS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY;

EID: 0032496208     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(98)00023-1     Document Type: Article

References (6)

1. Malamas M.S., Hohman T.C., Millen J. J. Med. Chem. 37:1994;2043.
2. Schmid R.W., Wolf C. J. Chromatogr. 478:1989;369.
3. Krull I.S., Selavka C.M., Lookabaugh M., Childress W.R. LC·GC. 7:1989;758.
4. Shah V.P., Midha K.K., Dighe S., McGilveray I.J., Skelly J.P., Jacobi A., Layott T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittman K.A., Spector S. J. Pharm. Sci. 81:1992;309.
5. Rocci M.L., Jusko W.J. Computer Programs Biomed. 16:1983;203.
6. Hohman T.C., Meng X., Tse S., Beg M., Neefe L., Bochenek W. Diabetes. 45:1996;S5A.